Home › Forums › Clinical Practice › prescribing GLP-1s in psychiatry › Reply To: prescribing GLP-1s in psychiatry

#1346
Shannon Minnehan

    I am a psychiatric nurse practitioner treating patients with a broad range of eating disorders. Unfortunately my experience with GLP-1s is taking patients with anorexia nervosa (or ARFID) off of them (after they have been procured by the patient or prescribed without any history taken).

    I echo what has been said above by others, and also agree with the difficulties of the siloed nature of the medical system. It is what makes us so adept at caring for certain populations, but also (without research across specialties) blind to the complexities of other aspects of health. I think my experiences in treating patients with ED likely obscures my judgment at times as well, it is the population I advocate and care for. I also am willing to look at other perspectives, which is not usually the case when I try to explain to others how to see things from an ED perspective. The brick wall is real. Why is “ob*sity” the public health concern? Are not eating disorders a public health concern? The Harvard School of Public Health thinks so. (https://hsph.harvard.edu/research/eating-disorders-striped/) Isn’t the weight centered narrative the one obscuring the real issue?

    I have trouble understanding why those with such strong feelings about promoting these meds are unable to look through a wider lens. As Dr Thomas wrote above, it is a real opportunity to look at the countertransference, the lack of individualized care and the disregard for adequate screening.

    I am so grateful for this group, and I wish you, Emily, luck and courage in having these discussions with your colleagues.